ID   S22AI_HUMAN             Reviewed;         424 AA.
AC   Q96BI1; O14906; O43562; O60485; O60680; Q7LDS5; Q7LGF7;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   26-MAY-2009, sequence version 3.
DT   15-MAR-2017, entry version 131.
DE   RecName: Full=Solute carrier family 22 member 18;
DE   AltName: Full=Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene A protein;
DE   AltName: Full=Efflux transporter-like protein;
DE   AltName: Full=Imprinted multi-membrane-spanning polyspecific transporter-related protein 1;
DE   AltName: Full=Organic cation transporter-like protein 2;
DE            Short=ORCTL-2;
DE   AltName: Full=Solute carrier family 22 member 1-like;
DE   AltName: Full=Tumor-suppressing STF cDNA 5 protein;
DE   AltName: Full=Tumor-suppressing subchromosomal transferable fragment candidate gene 5 protein;
DE   AltName: Full=p45-Beckwith-Wiedemann region 1 A;
DE            Short=p45-BWR1A;
GN   Name=SLC22A18;
GN   Synonyms=BWR1A, BWSCR1A, HET, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT GLN-309, AND VARIANT LUNG CANCER
RP   PHE-233.
RX   PubMed=9751628;
RA   Lee M.P., Reeves C., Schmitt A., Su K., Connors T.D., Hu R.J.,
RA   Brandenburg S., Lee M.J., Miller G., Feinberg A.P.;
RT   "Somatic mutation of TSSC5, a novel imprinted gene from human
RT   chromosome 11p15.5.";
RL   Cancer Res. 58:4155-4159(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9802569; DOI=10.1093/dnares/5.4.235;
RA   Morisaki H., Hatada I., Morisaki T., Mukai T.;
RT   "A novel gene, ITM, located between p57KIP2 and IPL, is imprinted in
RT   mice.";
RL   DNA Res. 5:235-240(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT GLN-12.
RX   PubMed=9570947; DOI=10.1006/geno.1998.5221;
RA   Cooper P.R., Smilinich N.J., Day C.D., Nowak N.J., Reid L.H.,
RA   Pearsall R.S., Reece M., Prawitt D., Landers J., Housman D.E.,
RA   Winterpacht A., Zabel B.U., Pelletier J., Weissman B.E., Shows T.B.,
RA   Higgins M.J.;
RT   "Divergently transcribed overlapping genes expressed in liver and
RT   kidney and located in the 11p15.5 imprinted domain.";
RL   Genomics 49:38-51(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=9499412; DOI=10.1093/hmg/7.4.597;
RA   Dao D., Frank D., Qian N., O'Keefe D., Vosatka R.J., Walsh C.P.,
RA   Tycko B.;
RT   "IMPT1, an imprinted gene similar to polyspecific transporter and
RT   multi-drug resistance genes.";
RL   Hum. Mol. Genet. 7:597-608(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANTS THR-6 AND GLN-12; CYS-86, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=9520460; DOI=10.1073/pnas.95.7.3873;
RA   Schwienbacher C., Sabbioni S., Campi M., Veronese A., Bernardi G.,
RA   Menegatti A., Hatada I., Mukai T., Ohashi H., Barbanti-Brodano G.,
RA   Croce C.M., Negrini M.;
RT   "Transcriptional map of 170-kb region at chromosome 11p15.5:
RT   identification and mutational analysis of the BWR1A gene reveals the
RT   presence of mutations in tumor samples.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:3873-3878(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-12.
RA   Chen P., Shen W., Karnik P.;
RT   "Monoallelic expression of the gene encoding a human efflux
RT   transporter like protein (HET), on chromosome 11p15.5.";
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-12.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9744804; DOI=10.1016/S0014-5793(98)00907-7;
RA   Reece M., Prawitt D., Landers J., Kast C., Gros P., Housman D.,
RA   Zabel B.U., Pelletier J.;
RT   "Functional characterization of ORCTL2 -- an organic cation
RT   transporter expressed in the renal proximal tubules.";
RL   FEBS Lett. 433:245-250(1998).
RN   [9]
RP   INTERACTION WITH RNF167.
RX   PubMed=16314844; DOI=10.1038/sj.onc.1209167;
RA   Yamada H.Y., Gorbsky G.J.;
RT   "Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel
RT   ubiquitin ligase RING105.";
RL   Oncogene 25:1330-1339(2006).
CC   -!- FUNCTION: May act as a transporter of organic cations based on a
CC       proton efflux antiport mechanism. May play a role in the transport
CC       of chloroquine and quinidine-related compounds in kidney.
CC       {ECO:0000269|PubMed:9744804}.
CC   -!- SUBUNIT: Interacts with RNF167. {ECO:0000269|PubMed:16314844}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane {ECO:0000305}; Multi-
CC       pass membrane protein {ECO:0000305}. Note=Localized at the apical
CC       membrane surface of renal proximal tubules.
CC       {ECO:0000269|PubMed:9744804}.
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in adult and fetal
CC       kidney and liver, and adult colon. Expressed in fetal renal
CC       proximal tubules (at protein level). Expressed at lower levels in
CC       heart, brain and lung. {ECO:0000269|PubMed:9499412,
CC       ECO:0000269|PubMed:9520460, ECO:0000269|PubMed:9570947,
CC       ECO:0000269|PubMed:9744804}.
CC   -!- DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy
CC       affecting tissues of the lung. The most common form of lung cancer
CC       is non-small cell lung cancer (NSCLC) that can be divided into 3
CC       major histologic subtypes: squamous cell carcinoma,
CC       adenocarcinoma, and large cell lung cancer. NSCLC is often
CC       diagnosed at an advanced stage and has a poor prognosis.
CC       {ECO:0000269|PubMed:9751628}. Note=The gene represented in this
CC       entry may be involved in disease pathogenesis.
CC   -!- DISEASE: Rhabdomyosarcoma, embryonal, 1 (RMSE1) [MIM:268210]: A
CC       form of rhabdomyosarcoma, a highly malignant tumor of striated
CC       muscle derived from primitive mesenchymal cells and exhibiting
CC       differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is
CC       one of the most frequently occurring soft tissue sarcomas and the
CC       most common in children. It occurs in four forms: alveolar,
CC       pleomorphic, embryonal and botryoidal rhabdomyosarcomas. Note=The
CC       disease may be caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the major facilitator (TC 2.A.1)
CC       superfamily. Organic cation transporter (TC 2.A.1.19) family.
CC       {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-17 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB82727.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA32779.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF059663; AAC14725.1; -; mRNA.
DR   EMBL; AB012083; BAA32779.1; ALT_INIT; mRNA.
DR   EMBL; AF037064; AAC04787.1; -; mRNA.
DR   EMBL; AF028738; AAB82727.1; ALT_INIT; mRNA.
DR   EMBL; AF030302; AAC17492.1; -; mRNA.
DR   EMBL; AF070479; AAC23505.1; -; mRNA.
DR   EMBL; BC015571; AAH15571.1; -; mRNA.
DR   CCDS; CCDS7740.1; -.
DR   RefSeq; NP_001302430.1; NM_001315501.1.
DR   RefSeq; NP_001302431.1; NM_001315502.1.
DR   RefSeq; NP_002546.3; NM_002555.5.
DR   RefSeq; NP_899056.2; NM_183233.2.
DR   UniGene; Hs.50868; -.
DR   ProteinModelPortal; Q96BI1; -.
DR   BioGrid; 111044; 26.
DR   IntAct; Q96BI1; 4.
DR   STRING; 9606.ENSP00000307859; -.
DR   TCDB; 2.A.1.2.53; the major facilitator superfamily (mfs).
DR   iPTMnet; Q96BI1; -.
DR   PhosphoSitePlus; Q96BI1; -.
DR   BioMuta; SLC22A18; -.
DR   DMDM; 238054368; -.
DR   EPD; Q96BI1; -.
DR   MaxQB; Q96BI1; -.
DR   PaxDb; Q96BI1; -.
DR   PeptideAtlas; Q96BI1; -.
DR   PRIDE; Q96BI1; -.
DR   DNASU; 5002; -.
DR   Ensembl; ENST00000312221; ENSP00000311139; ENSG00000110628.
DR   Ensembl; ENST00000347936; ENSP00000307859; ENSG00000110628.
DR   Ensembl; ENST00000380574; ENSP00000369948; ENSG00000110628.
DR   GeneID; 5002; -.
DR   KEGG; hsa:5002; -.
DR   UCSC; uc001lwx.3; human.
DR   CTD; 5002; -.
DR   DisGeNET; 5002; -.
DR   GeneCards; SLC22A18; -.
DR   H-InvDB; HIX0019391; -.
DR   HGNC; HGNC:10964; SLC22A18.
DR   HPA; HPA067812; -.
DR   HPA; HPA071461; -.
DR   MalaCards; SLC22A18; -.
DR   MIM; 114480; phenotype.
DR   MIM; 211980; phenotype.
DR   MIM; 268210; phenotype.
DR   MIM; 602631; gene.
DR   neXtProt; NX_Q96BI1; -.
DR   OpenTargets; ENSG00000110628; -.
DR   PharmGKB; PA35846; -.
DR   eggNOG; ENOG410IIP5; Eukaryota.
DR   eggNOG; ENOG4111F2C; LUCA.
DR   GeneTree; ENSGT00830000128359; -.
DR   HOVERGEN; HBG082086; -.
DR   InParanoid; Q96BI1; -.
DR   KO; K08214; -.
DR   OMA; LMWPSFL; -.
DR   OrthoDB; EOG091G0H3E; -.
DR   PhylomeDB; Q96BI1; -.
DR   TreeFam; TF352510; -.
DR   Reactome; R-HSA-549127; Organic cation transport.
DR   GeneWiki; SLC22A18; -.
DR   GenomeRNAi; 5002; -.
DR   PRO; PR:Q96BI1; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000110628; -.
DR   CleanEx; HS_SLC22A18; -.
DR   ExpressionAtlas; Q96BI1; baseline and differential.
DR   Genevisible; Q96BI1; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015238; F:drug transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015307; F:drug:proton antiporter activity; TAS:Reactome.
DR   GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0015893; P:drug transport; IDA:UniProtKB.
DR   GO; GO:0007588; P:excretion; NAS:UniProtKB.
DR   GO; GO:0015695; P:organic cation transport; NAS:UniProtKB.
DR   CDD; cd06174; MFS; 1.
DR   InterPro; IPR011701; MFS.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR001958; Tet-R_TetA/multi-R_MdtG.
DR   Pfam; PF07690; MFS_1; 1.
DR   PRINTS; PR01035; TCRTETA.
DR   SUPFAM; SSF103473; SSF103473; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disease mutation; Ion transport;
KW   Membrane; Polymorphism; Reference proteome; Symport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    424       Solute carrier family 22 member 18.
FT                                /FTId=PRO_0000220509.
FT   TRANSMEM     26     46       Helical. {ECO:0000255}.
FT   TRANSMEM     59     79       Helical. {ECO:0000255}.
FT   TRANSMEM     90    110       Helical. {ECO:0000255}.
FT   TRANSMEM    156    176       Helical. {ECO:0000255}.
FT   TRANSMEM    184    204       Helical. {ECO:0000255}.
FT   TRANSMEM    243    263       Helical. {ECO:0000255}.
FT   TRANSMEM    276    296       Helical. {ECO:0000255}.
FT   TRANSMEM    312    332       Helical. {ECO:0000255}.
FT   TRANSMEM    334    354       Helical. {ECO:0000255}.
FT   TRANSMEM    391    411       Helical. {ECO:0000255}.
FT   VARIANT       6      6       A -> T (in dbSNP:rs1048046).
FT                                {ECO:0000269|PubMed:9520460}.
FT                                /FTId=VAR_055406.
FT   VARIANT      12     12       R -> Q (in dbSNP:rs1048047).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9520460,
FT                                ECO:0000269|PubMed:9570947,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_055407.
FT   VARIANT      86     86       R -> C (in a rhabdomyosarcoma sample).
FT                                {ECO:0000269|PubMed:9520460}.
FT                                /FTId=VAR_024061.
FT   VARIANT     233    233       S -> F (in lung cancer; somatic mutation;
FT                                dbSNP:rs121909071).
FT                                {ECO:0000269|PubMed:9751628}.
FT                                /FTId=VAR_024062.
FT   VARIANT     309    309       R -> Q (in dbSNP:rs141165353).
FT                                {ECO:0000269|PubMed:9751628}.
FT                                /FTId=VAR_024063.
FT   VARIANT     324    324       W -> C (in dbSNP:rs1129782).
FT                                /FTId=VAR_055408.
FT   CONFLICT     84     84       D -> N (in Ref. 5; AAC17492).
FT                                {ECO:0000305}.
FT   CONFLICT    227    227       D -> E (in Ref. 4; AAB82727 and 6;
FT                                AAC23505). {ECO:0000305}.
FT   CONFLICT    230    230       A -> G (in Ref. 4; AAB82727 and 6;
FT                                AAC23505). {ECO:0000305}.
FT   CONFLICT    242    242       R -> K (in Ref. 4; AAB82727 and 6;
FT                                AAC23505). {ECO:0000305}.
FT   CONFLICT    275    275       Q -> K (in Ref. 4; AAB82727 and 6;
FT                                AAC23505). {ECO:0000305}.
FT   CONFLICT    307    307       L -> M (in Ref. 3; AAC04787).
FT                                {ECO:0000305}.
FT   CONFLICT    309    309       R -> G (in Ref. 4; AAB82727 and 6;
FT                                AAC23505). {ECO:0000305}.
SQ   SEQUENCE   424 AA;  44846 MW;  9EFD5F902A77A6E8 CRC64;
     MQGARAPRDQ GRSPGRMSAL GRSSVILLTY VLAATELTCL FMQFSIVPYL SRKLGLDSIA
     FGYLQTTFGV LQLLGGPVFG RFADQRGARA ALTLSFLAAL ALYLLLAAAS SPALPGVYLL
     FASRLPGALM HTLPAAQMVI TDLSAPEERP AALGRLGLCF GVGVILGSLL GGTLVSAYGI
     QCPAILAALA TLLGAVLSFT CIPASTKGAK TDAQAPLPGG PRASVFDLKA IASLLRLPDV
     PRIFLVKVAS NCPTGLFMVM FSIISMDFFQ LEAAQAGYLM SFFGLLQMVT QGLVIGQLSS
     HFSEEVLLRA SVLVFIVVGL AMAWMSSVFH FCLLVPGLVF SLCTLNVVTD SMLIKAVSTS
     DTGTMLGLCA SVQPLLRTLG PTVGGLLYRS FGVPVFGHVQ VAINTLVLLV LWRKPMPQRK
     DKVR
//
